Prof G: The problem with off label prescriptions in multiple sclerosis.

In this video Rachel interviews Professor Gavin Giovannoni who is a Consultant Neurologist. The interview was filmed by Rob

Video transcript

Ocrelizumab was being reviewed by NICE as the first licensed treatment for Primary Progressive MS. NICE have decided not to recommend the drug – but it would still be available if people were willing to pay the price. Prof G talks about the problems with prescribing off license treatments.

If you think it’s unfair that NICE aren’t recommending the first licensed drug for primary progressive MS, Gavin recommends writing to your MP. We’ve put together a template letter to download on this link.

Expert: Gavin Giovannoni, Consultant Neurologist, BARTS, London

MS Reporter: Rachel

More videos about Treatment category

Leave a Reply

Have you found this video useful? Please let us know by filling in this short survey.
Join the communityclose